The progression of cancer involves a critical step in which malignant cells escape from
control by the immune system. Antineoplastic agents are particularly efficient when they …

Breast cancer (BC) is the most common cancer in women worldwide. Although substantial
progress has been made in the diagnosis and treatment of breast cancer, the efficacy and …

Background While neoadjuvant immunotherapy for melanoma has shown promising results,
the data have been limited by a relatively short follow-up time, with most studies reporting 2 …

Abstract The 2022 yearly Think Tank Meeting in Siena, Tuscany (Italy), organized by the
Italian Network for Tumor Biotherapy (NIBIT) Foundation, the Parker Institute for Cancer …

Background Upper urinary tract urothelial carcinoma (UTUC) is often locally advanced at
initial diagnosis and is associated with high recurrence and mortality rates after radical …

Abstract Bacillus Calmette-Guerin (BCG) is a live attenuated Mycobacterium bovis strain,
originally developed as a vaccine against tuberculosis. It is also the only bacterial cancer …

Purpose We aimed to investigate the pathological changes, clinicopathological correlation
and prognostic factors of neoadjuvant programmed cell death 1 (PD-1) blockade …

Advanced head and neck cancer (HNC) is functionally and aesthetically destructive, and
despite significant advances in therapy, overall survival is poor, financial toxicity is high, and …

Abstract The Great Debate session at the 2022 Melanoma Bridge congress (December 1–3)
featured counterpoint views from leading experts on five contemporary topics of debate in …

Management of Localized Melanoma in the Anti-PD-1 Era | Current Oncology Reports Skip to
main content SpringerLink Account Menu Find a journal Publish with us Track your research …